D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 42 Citations 10,592 100 World Ranking 3797 National Ranking 1727

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Disease

David Wofsy mainly focuses on Internal medicine, Immunology, Antibody, Monoclonal antibody and Autoimmunity. David Wofsy has included themes like Gastroenterology and Endocrinology in his Internal medicine study. His studies in Murine lupus and CD28 are all subfields of Immunology research.

His study explores the link between Antibody and topics such as Antigen that cross with problems in T cell. His Autoimmunity research is within the category of Immune system. His Lupus nephritis research incorporates themes from Cyclophosphamide, Pharmacology and Prednisone.

His most cited work include:

  • Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis (678 citations)
  • Treatment of murine lupus with CTLA4Ig (669 citations)
  • Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. (404 citations)

What are the main themes of his work throughout his whole career to date?

David Wofsy mainly investigates Immunology, Internal medicine, Lupus nephritis, Immune system and Autoimmunity. Autoimmune disease, Antibody, Monoclonal antibody, Antigen and T cell are the core of his Immunology study. His Internal medicine study combines topics in areas such as Gastroenterology, Placebo and Endocrinology.

His Lupus nephritis study also includes

  • Cyclophosphamide that intertwine with fields like Kidney disease,
  • Randomized controlled trial that connect with fields like Clinical trial and Disease activity. His Immune system research is multidisciplinary, incorporating elements of Interferon and B cell. His Autoimmunity research includes elements of Pathogenesis, Blockade, Immune tolerance, Lymph node and T-cell costimulation.

He most often published in these fields:

  • Immunology (61.11%)
  • Internal medicine (48.15%)
  • Lupus nephritis (29.01%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (48.15%)
  • Lupus nephritis (29.01%)
  • Immunology (61.11%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Lupus nephritis, Immunology, Placebo and Systemic lupus erythematosus. His research in Internal medicine intersects with topics in Anti-nuclear antibody, Gastroenterology and B-cell activating factor. His Lupus nephritis research is multidisciplinary, relying on both CD8, Kidney, Proteinuria, B cell and Nephritis.

Immune system, Autoimmunity and Autoimmune disease are subfields of Immunology in which his conducts study. His biological study spans a wide range of topics, including Atacicept and Pharmacodynamics. His work in Systemic lupus erythematosus addresses subjects such as Clinical trial, which are connected to disciplines such as Randomized controlled trial.

Between 2016 and 2021, his most popular works were:

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (197 citations)
  • 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus (173 citations)
  • The immune cell landscape in kidneys of patients with lupus nephritis (132 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Disease

His primary areas of investigation include Internal medicine, Anti-nuclear antibody, Rheumatology, Immunology and Lupus erythematosus. His studies deal with areas such as Gastroenterology and B-cell activating factor as well as Internal medicine. He frequently studies issues relating to Lupus nephritis and Immunology.

In his work, Atacicept, Post-hoc analysis, Randomized controlled trial and Clinical trial is strongly intertwined with Placebo, which is a subfield of Lupus erythematosus. His Autoimmunity research incorporates elements of Acquired immune system, T cell, B cell, CD11c and Immunotherapy. The study incorporates disciplines such as Inflammation, Adoptive cell transfer, Kidney metabolism and Immune system in addition to Autoimmune disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks.
Arthritis & Rheumatism (2019)

1231 Citations

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)

1172 Citations

Treatment of murine lupus with CTLA4Ig.

Barbara K. Finck;Peter S. Linsley;David Wofsy.
Science (1994)

1054 Citations

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

D Wofsy;W E Seaman.
Journal of Experimental Medicine (1985)

637 Citations

Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis

Mary Anne Dooley;David Jayne;Ellen M. Ginzler;David Isenberg.
The New England Journal of Medicine (2011)

622 Citations

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.

Kenneth C. Kalunian;John C. Davis;Joan T. Merrill;Mark C. Totoritis.
Arthritis & Rheumatism (2002)

472 Citations

Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial.

Maria Dall'Era;Eliza Chakravarty;Daniel Wallace;Mark Genovese.
Arthritis & Rheumatism (2007)

416 Citations

Professional Medical Associations and Their Relationships With Industry: A Proposal for Controlling Conflict of Interest

David J. Rothman;Walter J. McDonald;Carol D. Berkowitz;Susan C. Chimonas.
JAMA (2009)

357 Citations

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

David Isenberg;Gerald B. Appel;Gabriel Contreras;Mary A. Dooley.
Rheumatology (2010)

346 Citations

Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells.

J A Ledbetter;P J Martin;C E Spooner;D Wofsy.
Journal of Immunology (1985)

345 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Wofsy

David A. Isenberg

David A. Isenberg

University College London

Publications: 62

Brad H. Rovin

Brad H. Rovin

The Ohio State University

Publications: 46

Shozo Izui

Shozo Izui

University of Geneva

Publications: 40

Herman Waldmann

Herman Waldmann

University of Oxford

Publications: 39

George C. Tsokos

George C. Tsokos

Harvard Medical School

Publications: 37

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 34

Dimitrios T. Boumpas

Dimitrios T. Boumpas

National and Kapodistrian University of Athens

Publications: 34

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 34

Caroline Gordon

Caroline Gordon

University of Birmingham

Publications: 32

Daniel J. Wallace

Daniel J. Wallace

University of California, Los Angeles

Publications: 32

Tak Mao Chan

Tak Mao Chan

University of Hong Kong

Publications: 32

Joan T. Merrill

Joan T. Merrill

Oklahoma Medical Research Foundation

Publications: 31

David Jayne

David Jayne

University of Cambridge

Publications: 31

Graciela S. Alarcón

Graciela S. Alarcón

University of Alabama at Birmingham

Publications: 30

Thomas Dörner

Thomas Dörner

Charité - University Medicine Berlin

Publications: 30

Argyrios N. Theofilopoulos

Argyrios N. Theofilopoulos

Scripps Research Institute

Publications: 29

Trending Scientists

H. El Gamal

H. El Gamal

University of Sydney

Richard Vidgen

Richard Vidgen

University of New South Wales

Colin Kirkpatrick

Colin Kirkpatrick

University of Manchester

Balbir S. Dhillon

Balbir S. Dhillon

University of Ottawa

Dennis H. Evans

Dennis H. Evans

University of Delaware

Fabio B. Noronha

Fabio B. Noronha

Military Institute of Engineering

David Beach

David Beach

Cold Spring Harbor Laboratory

Amparo Querol

Amparo Querol

Spanish National Research Council

Roy A. Black

Roy A. Black

University of Washington

Glenn A. Milne

Glenn A. Milne

University of Ottawa

Mian Liu

Mian Liu

University of Missouri

Robert H. Logie

Robert H. Logie

University of Edinburgh

Jean-Paul Sculier

Jean-Paul Sculier

Université Libre de Bruxelles

Steven H. Graham

Steven H. Graham

University of Pittsburgh

Robert F. Schoeni

Robert F. Schoeni

University of Michigan–Ann Arbor

Something went wrong. Please try again later.